Skip to Main Content

Paper Details

Correction: A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory.
Oncotarget
0
2019
Author NameAffiliation
Kenna R Mills ShawSheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center
Kenna R Mills ShawSheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center
Ken ChenThe University of Texas MD Anderson Cancer Center
Scott KopetzThe University of Texas MD Anderson Cancer Center
Mark J RoutbortThe University of Texas MD Anderson Cancer Center
Elmer V BernstamThe University of Texas Health Science Center at Houston
Elmer V BernstamThe University of Texas Health Science Center at Houston
Gordon B MillsSheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center
Gordon B MillsThe University of Texas MD Anderson Cancer Center
Gordon B MillsSheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center
Gordon B MillsThe University of Texas MD Anderson Cancer Center
Funda Meric-BernstamThe University of Texas MD Anderson Cancer Center
Funda Meric-BernstamSheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center
Funda Meric-BernstamThe University of Texas MD Anderson Cancer Center
  • 1 - 14

Datasets

Release 1.2